Wird geladen...
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
Immunotherapy has become a mainstay of cancer treatment in many malignancies, though its application in breast cancer remains limited. Of the breast cancer subtypes, triple-negative breast cancers (TNBCs) are characterized by immune activation and infiltration and more commonly express biomarkers as...
Gespeichert in:
| Veröffentlicht in: | Cancer Metastasis Rev |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184866/ https://ncbi.nlm.nih.gov/pubmed/34101053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-021-09972-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|